Skoltech researchers and their colleagues from Ludwig Maximilian University of Munich, Germany, Nanjing University of China, ...

Any molecular biologist will tell you that genetic engineering is tricky. But up until recently we might be witnessing a new age in human development. Hosted by: Michael Aranda Dooblydoo thanks go to ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

Scribe Therapeutics, Inc. (Scribe), a biotechnology company pioneering highly engineered CRISPR technologies designed to reshape the treatment of disease by enabling earlier intervention, improved ...

Canadian filmmaker Cole Walliser, who rose to fame as the director of the red carpet sensation, Glambot, has come under scrutiny over an alleged conversation with one of his clients, Yinka Animashaun.

Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.

Investigators used genetic genealogy to identify the 1966 Geneseo John Doe as 19-year-old Ronald Joe Cole, missing from ...

Detailed price information for Prime Medicine Inc (PRME-Q) from The Globe and Mail including charting and trades.

Gene-editing technologies show great promise for medical treatments and research, with the potential to cure thousands of ...

Cystic fibrosis (CF) is the most prevalent inherited disease. Inactivating mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene lead to the accumulation of viscous mucus ...

Revolutions in gene therapy are rapidly changing the landscape of modern medicine. Revolutions in gene therapy are rapidly changing the landscape of modern medicine, forcing society and science alike ...

C&EN’s award-winning podcast Inflection Point leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three ...